Press "Enter" to skip to content

New patent expiration for Allergan Sales drug RAPAFLO

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan Sales drug RAPAFLO

Annual Drug Patent Expirations for RAPAFLO
Annual Drug Patent Expirations for RAPAFLO

Rapaflo is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

RAPAFLO drug price trends.

Drug patent litigation for RAPAFLO.

This drug has six patent family members in four countries.

The generic ingredient in RAPAFLO is silodosin. Two suppliers are listed for this compound. Additional details are available on the silodosin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan Sales drug RAPAFLO
    Do NOT follow this link or you will be banned from the site!